BRIEF-Mitsubishi Ufj Spokesperson Declines To Comment On Report Of Seven & I Management Buyout Deal-February 2024-www.financetom.com

BRIEF-Mitsubishi Ufj Spokesperson Declines To Comment On Report Of Seven & I Management Buyout Deal

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Mitsubishi Ufj Spokesperson Declines To Comment On Report Of Seven & I Management Buyout Deal

Nov 12, 2024 7:36 PM

Nov 13 (Reuters) - Seven & i Holdings Co Ltd ( SVNDF ):

* MITSUBISHI UFJ SPOKESPERSON DECLINES TO COMMENT ON REPORT

SEVEN & I MANAGEMENT BUYOUT DEAL

Source text:

Further company coverage:

(Reporting by Tokyo Newsroom)

Previous page： Genasys Insider Bought Shares Worth $264,000, According to a Recent SEC Filing Next page： Palvella Therapeutics Completes Merger with Pieris; Raises $78.9 Million in Private Placement

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Genasys Insider Bought Shares Worth $264,000, According to a Recent SEC Filing

Dec 13, 2024

03:42 PM EST, 12/13/2024 (MT Newswires) -- Richard Hoe Osgood III, Director, on December 12, 2024, executed a purchase for 100,000 shares in Genasys ( GNSS ) for $264,000. Following the Form 4 filing with the SEC, Osgood has control over a total of 507,883 shares of the company, with 507,883 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/924383/000143774924037461/xslF345X05/rdgdoc.xml Price: 2.70, Change:...

Palvella Therapeutics Completes Merger with Pieris; Raises $78.9 Million in Private Placement

Dec 13, 2024

03:35 PM EST, 12/13/2024 (MT Newswires) -- Palvella Therapeutics (PVLA) said Friday it has completed its merger with Pieris Pharmaceutical. The merged entity will be named Palvella Therapeutics, with its shares set to start trading on the Nasdaq Capital Market under the ticker PVLA on Monday. The clinical-stage biopharmaceutical company said it raised $78.9 million in a private placement co-led...

J&J accuses divisions of Cigna of helping drain its drug copay funds, WSJ reports

Dec 13, 2024

Dec 13 (Reuters) - Johnson & Johnson ( JNJ ) has sued divisions of Cigna ( CI ), accusing the health insurer of working with a drug-benefit middleman to drain J&J's financial-assistance funds earmarked for patients taking some of its pricier drugs, The Wall Street Journal reported on Friday. ...

Market Chatter: Post Looking to Acquire Lamb Weston

Dec 13, 2024

03:45 PM EST, 12/13/2024 (MT Newswires) -- Post Holdings ( POST ) is looking to acquire Lamb Weston ( LW ) and has retained investment bankers to assist with striking a deal, Reuters reported Friday, citing two sources familiar with the matter. In October, activist investor Jana Partners disclosed a 5% equity stake in the frozen potatoes company and reportedly...